An update on complications associated with transcatheter aortic valve implantation: Stroke, paravalvular leak, atrioventricular block and perforation

Future Cardiology

Volumn 9, Issue 5, 2013, Pages 733-747

  Chiam, Paul T L ^a   Ewe, See Hooi ^a  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

Author keywords

Aortic regurgitation; Aortic valve replacement; Aortic valve stenosis; Atrioventricular block; Pacemaker; Perforation; Prosthesis; Stroke; Transcatheter aortic valve implantation

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; NITINOL;

ACUTE KIDNEY FAILURE; ANTICOAGULANT THERAPY; AORTA PRESSURE; AORTA RUPTURE; AORTA STENOSIS; AORTA VALVE; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTIC VALVE REPAIR; AORTOGRAPHY; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BLOOD VESSEL INJURY; BRAIN CIRCULATION; BRAIN EMBOLISM; BRAIN PERFUSION; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FOLLOW UP; HEALTH CARE QUALITY; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART BUNDLE BRANCH BLOCK; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT ATRIUM; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE PERFORATION; HEART VENTRICLE SEPTUM; HIS BUNDLE; HUMAN; INCIDENCE; META ANALYSIS (TOPIC); MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE; PATHOPHYSIOLOGY; PERFORATION; PR INTERVAL; PRESSURE GRADIENT; PRIORITY JOURNAL; REVIEW; SAFETY; SYSTOLIC BLOOD PRESSURE; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSCRANIAL DOPPLER; TRANSIENT ISCHEMIC ATTACK; TRANSLUMINAL VALVULOPLASTY; TRICUSPID VALVE;

AORTIC VALVE STENOSIS; ATRIOVENTRICULAR BLOCK; CARDIAC CATHETERIZATION; HEART INJURIES; HEART VALVE PROSTHESIS IMPLANTATION; HEART VENTRICLES; HUMANS; RUPTURE; STROKE; TREATMENT FAILURE;

EID: 84884126833     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/FCA.13.43     Document Type: Review

References (97)

1. Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106(24), 3006-3008 (2002).
2. Leon MB, Smith CR, Mack M et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363(17), 1597-1607 (2010).
3. Makkar RR, Fontana GP, Jilaihawi H et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N. Engl. J. Med. 366(18), 1696-1704 (2012).
4. Smith CR, Leon MB, Mack MJ et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 364(23), 2187-2198 (2011).
5. Kodali SK, Williams MR, Smith CR et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N. Engl. J. Med. 366(18), 1686-1695 (2012).
6. Chiam PT, Ruiz CE. Percutaneous transcatheter aortic valve implantation: evolution of the technology. Am. Heart J. 157(2), 229-242 (2009).
7. Kappetein AP, Head SJ, Genereux P et al. Updated standardized end point definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J. Am. Coll. Cardiol. 60(15), 1438-1454 (2012).
8. Leon MB, Piazza N, Nikolsky E et al. Standardized end point definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur. Heart J. 32(2), 205-217 (2011).
9. Thomas M, Schymik G, Walther T et al. Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122(1), 62-69 (2010).
10. Gilard M, Eltchaninoff H, Iung B et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N. Engl. J. Med. 366(18), 1705-1715 (2012).
11. Di Mario C, Eltchaninoff H, Moat N et al. The 2011-2012 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients. EuroIntervention 8(12), 1362-1371 (2012).
12. Nombela-Franco L, Webb JG, De Jaegere PP et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation 126(25), 3041-3053 (2012).
13. Eggebrecht H, Schmermund A, Voigtlander T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 8(1), 129-138 (2012).
14. Moat NE, Ludman P, De Belder MA et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J. Am. Coll. Cardiol. 58(20), 2130-2138 (2011).
15. Zahn R, Gerckens U, Grube E et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur. Heart J. 32(2), 198-204 (2011).
16. Tamburino C, Capodanno D, Ramondo A et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123(3), 299-308 (2011).
17. Daneault B, Kirtane AJ, Kodali SK et al. Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review. J. Am. Coll. Cardiol. 58(21), 2143-2150 (2011).
18. Kahlert P, Knipp SC, Schlamann M et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 121(7), 870-878 (2010).
19. Rodés-Cabau J, Dumont E, Boone RH et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J. Am. Coll. Cardiol. 57(1), 18-28 (2011).
20. Kahlert P, Al-Rashid F, Dottger P et al. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation 126(10), 1245-1255 (2012).
21. Erdoes G, Basciani R, Huber C et al. Transcranial Doppler-detected cerebral embolic load during transcatheter aortic valve implantation. Eur. J. Cardiothorac. Surg. 41(4), 778-783; discussion 783-774 (2012).
22. Nietlispach F, Wijesinghe N, Gurvitch R et al. An embolic deflection device for aortic valve interventions. JACC Cardiovasc. Interv. 3(11), 1133-1138 (2010).
23. Onsea K, Agostoni P, Samim M et al. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions. EuroIntervention 8(1), 51-56 (2012).
24. Naber CK, Ghanem A, Abizaid AA et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention 8(1), 43-50 (2012).
25. Nietlispach F, Johnson M, Moss RR et al. Transcatheter closure of paravalvular defects using a purpose-specific occluder. JACC Cardiovasc. Interv. 3(7), 759-765 (2010).
26. Abdel-Wahab M, Zahn R, Horack M et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart 97(11), 899-906 (2011).
27. Sellers RD, Levy MJ, Amplatz K, Lillehei CW. Left retrograde cardioangiography in acquired cardiac disease: technic, indications and interpretations in 700 cases. Am. J. Cardiol. 14, 437-447 (1964).
28. Zoghbi WA, Chambers JB, Dumesnil JG et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 22(9), 975-1014; quiz 1082-1014 (2009).
29. Sinning JM, Hammerstingl C, Vasa-Nicotera M et al. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J. Am. Coll. Cardiol. 59(13), 1134-1141 (2012).
30. Patsalis P KT, Al-Rashid F et al. Incidence, outcome and correlates of residua paravalvular aortic regurgitation after transcatheter aortic valve implantation and importance of hemodynamic assessment. EuroIntervention 8(12), 1398-1406 (2012).
31. Goncalves A AC, Marcos-Alberca P et al.Three-dimensional echocardiography in paravalvular aortic regurgitation assessment after transcatheter aortic valve implantation. J. Am. Soc. Echocardiogr. 25(1), 47-55 (2012).
32. Lang RM, Badano LP, Tsang W et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J. Am. Soc. Echocardiogr. 25(1), 3-46 (2012).
33. Sherif MA, Abdel-Wahab M, Beurich HW et al. Haemodynamic evaluation of aortic regurgitation after transcatheter aortic valve implantation using cardiovascular magnetic resonance. EuroIntervention 7(1), 57-63 (2011).
34. Ussia GP, Barbanti M, Petronio AS et al. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur. Heart J. 33(8), 969-976 (2012).
35. Buellesfeld L, Gerckens U, Schuler G et al. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J. Am. Coll. Cardiol. 57(16), 1650-1657 (2011).
36. Toggweiler S, Humphries K, Lee M et al. 5-year outcome after transcatheter aortic valve implantation. J. Am. Coll. Cardiol. 61(4), 413-419 (2013).
37. Gurvitch R, Webb JG, Yuan R et al. Aortic annulus diameter determination by multidetector computed tomography: reproducibility, applicability, and implications for transcatheter aortic valve implantation. JACC Cardiovasc. Interv. 4(11), 1235-1245 (2011).
38. Ng AC, Delgado V, Van Der Kley F et al. Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2-and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circ. Cardiovasc. Imaging 3(1), 94-102 (2010).
39. Achenbach S, Delgado V, Hausleiter J, Schoenhagen P, Min JK, Leipsic JA. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J. Cardiovasc. Comput. Tomogr. 6(6), 366-380 (2012).
40. Jilaihawi H, Kashif M, Fontana G et al. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J. Am. Coll. Cardiol. 59(14), 1275-1286 (2012).
41. Hayashida K, Bouvier E, Lefevre T et al. Impact of CT-guided valve sizing on post-procedural aortic regurgitation in transcatheter aortic valve implantation. EuroIntervention 8(5), 546-555 (2012).
42. Detaint D, Lepage L, Himbert D et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc. Interv. 2(9), 821-827 (2009).
43. Gripari P, Ewe SH, Fusini L et al. Intraoperative 2D and 3D transoesophageal echocardiographic predictors of aortic regurgitation after transcatheter aortic valve implantation. Heart 98(16), 1229-1236 (2012).
44. Willson AB, Webb JG, Labounty TM et al. 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J. Am. Coll. Cardiol. 59(14), 1287-1294 (2012).
45. Blanke P, Reinohl J, Schlensak C et al. Prosthesis oversizing in balloon-expandable transcatheter aortic valve implantation is associated with contained rupture of the aortic root. Circ. Cardiovasc. Interv. 5(4), 540-548 (2012).
46. Colli A, D'amico R, Kempfert J, Borger MA, Mohr FW, Walther T. Transesophageal echocardiographic scoring for transcatheter aortic valve implantation: impact of aortic cusp calcification on postoperative aortic regurgitation. J. Thorac. Cardiovasc. Surg. 142(5), 1229-1235 (2011).
47. Delgado V, Ng AC, Van De Veire NR et al. Transcatheter aortic valve implantation: role of multi-detector row computed tomography to evaluate prosthesis positioning and deployment in relation to valve function. Eur. Heart J. 31(9), 1114-1123 (2010).
48. Haensig M, Lehmkuhl L, Rastan AJ et al. Aortic valve calcium scoring is a predictor of significant paravalvular aortic insufficiency in transapical-aortic valve implantation. Eur. J. Cardiothorac. Surg. 41(6), 1234-1240; discussion 1240-1241 (2012).
49. John D, Buellesfeld L, Yuecel S et al. Correlation of device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis. JACC Cardiovasc. Interv. 3(2), 233-243 (2010).
50. Schultz CJ, Tzikas A, Moelker A et al. Correlates on MSCT of paravalvular aortic regurgitation after transcatheter aortic valve implantation using the Medtronic CoreValve prosthesis. Catheter. Cardiovasc. Interv. 78(3), 446-455 (2011).
51. Unbehaun A, Pasic M, Dreysse S et al. Transapical aortic valve implantation: incidence and predictors of paravalvular leakage and transvalvular regurgitation in a series of 358 patients. J. Am. Coll. Cardiol. 59(3), 211-221 (2012).
52. Ewe SH, Ng AC, Schuijf JD et al. Location and severity of aortic valve calcium and implications for aortic regurgitation after transcatheter aortic valve implantation. Am. J. Cardiol. 108(10), 1470-1477 (2011).
53. Himbert D, Pontnau F, Messika-Zeitoun D et al. Feasibility and outcomes of transcatheter aortic valve implantation in high-risk patients with stenotic bicuspid aortic valves. Am. J. Cardiol. 110(6), 877-883 (2012).
54. Sherif MA, Abdel-Wahab M, Stocker B et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J. Am. Coll. Cardiol. 56(20), 1623-1629 (2010).
55. Toggweiler S, Wood DA, Rodés-Cabau J et al. Transcatheter valve-in-valve implantation for failed balloon-expandable transcatheter aortic valves. JACC Cardiovasc. Interv. 5(5), 571-577 (2012).
56. Stortecky S, Buellesfeld L, Wenaweser P, Windecker S. Transcatheter aortic valve implantation: prevention and management of complications. Heart 98(Suppl. 4), IV52-IV64 (2012).
57. Ussia GP, Barbanti M, Ramondo A et al. The valve-in-valve technique for treatment of aortic bioprosthesis malposition an analysis of incidence and 1-year clinical outcomes from the italian CoreValve registry. J. Am. Coll. Cardiol. 57(9), 1062-1068 (2011).
58. Binder RK, Rodes-Cabau J, Wood DA et al. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. JACC Cardiovasc. Interv. 6(3), 293-300 (2013).
59. Willson AB, Rodes-Cabau J, Wood DA et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience. J. Am. Coll. Cardiol. 60(7), 581-586 (2012).
60. Binder RK, Schafer U, Kuck KH et al. Transcatheter aortic valve replacement with a new self-expanding transcatheter heart valve and motorized delivery system. JACC Cardiovasc. Interv. 6(3), 301-307 (2013).
61. Bijuklic K, Tuebler T, Reichenspurner H et al. Midterm stability and hemodynamic performance of a transfemorally implantable nonmetallic, retrievable, and repositionable aortic valve in patients with severe aortic stenosis. Up to 2-year follow-up of the direct-flow medical valve: a pilot study. Circ. Cardiovasc. Interv. 4(6), 595-601 (2011).
62. El-Khally Z, Thibault B, Staniloae C et al. Prognostic significance of newly acquired bundle branch block after aortic valve replacement. Am. J. Cardiol. 94(8), 1008-1011 (2004).
63. Thomas JL, Dickstein RA, Parker FB Jr et al. Prognostic significance of the development of left bundle conduction defects following aortic valve replacement. J. Thorac. Cardiovasc. Surg. 84(3), 382-386 (1982).
64. Limongelli G, Ducceschi V, D'andrea A et al. Risk factors for pacemaker implantation following aortic valve replacement: a single centre experience. Heart 89(8), 901-904 (2003).
65. Dawkins S, Hobson AR, Kalra PR, Tang AT, Monro JL, Dawkins KD. Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors. Ann. Thorac. Surg. 85(1), 108-112 (2008).
66. Piazza N, Onuma Y, Jesserun E et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc. Interv. 1(3), 310-316 (2008).
67. Rodés-Cabau J, Webb JG, Cheung A et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J. Am. Coll. Cardiol. 55(11), 1080-1090 (2010).
68. Sinhal A, Altwegg L, Pasupati S et al. Atrioventricular block after transcatheter balloon expandable aortic valve implantation. JACC Cardiovasc. Interv. 1(3), 305-309 (2008).
69. Laynez A, Ben-Dor I, Barbash IM et al. Frequency of conduction disturbances after Edwards SAPIEN percutaneous valve implantation. Am. J. Cardiol. 110(8), 1164-1168 (2012).
70. Bagur R, Rodes-Cabau J, Gurvitch R et al. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. JACC Cardiovasc. Interv. 5(5), 540-551 (2012).
71. Godin M, Eltchaninoff H, Furuta A et al. Frequency of conduction disturbances after transcatheter implantation of an Edwards SAPIEN aortic valve prosthesis. Am. J. Cardiol. 106(5), 707-712 (2010).
72. Khawaja MZ, Rajani R, Cook A et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation 123(9), 951-960 (2011).
73. Genereux P, Head SJ, Van Mieghem NM et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J. Am. Coll. Cardiol. 59(25), 2317-2326 (2012).
74. Houthuizen P, Van Garsse LA, Poels TT et al. Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation 126(6), 720-728 (2012).
75. Aktug O, Dohmen G, Brehmer K et al. Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation. Int. J. Cardiol. 160(1), 26-30 (2012).
76. Urena M, Mok M, Serra V et al. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J. Am. Coll. Cardiol. 60(18), 1743-1752 (2012).
77. Nuis RJ, Van Mieghem NM, Schultz CJ et al. Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis. Eur. Heart J. 32(16), 2067-2074 (2011).
78. Roten L, Wenaweser P, Delacretaz E et al. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am. J. Cardiol. 106(10), 1473-1480 (2010).
79. Gutierrez M, Rodes-Cabau J, Bagur R et al. Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation. Am. Heart J. 158(2), 302-308 (2009).
80. Haworth P, Behan M, Khawaja M et al. Predictors for permanent pacing after transcatheter aortic valve implantation. Catheter Cardiovasc. Interv. 76(5), 751-756 (2010).
81. Rubin JM, Avanzas P, Del Valle R et al. Atrioventricular conduction disturbance characterization in transcatheter aortic valve implantation with the CoreValve prosthesis. Circ. Cardiovasc. Interv. 4(3), 280-286 (2011).
82. Moreno R, Dobarro D, Lopez De Sa E et al. Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study. Circulation 120(5), e29-e30 (2009).
83. Piazza N, Nuis RJ, Tzikas A et al. Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. EuroIntervention 6(4), 475-484 (2010).
84. Munoz-Garcia AJ, Hernandez-Garcia JM, Jimenez-Navarro MF et al. Factors predicting and having an impact on the need for a permanent pacemaker after CoreValve prosthesis implantation using the new Accutrak delivery catheter system. JACC Cardiovasc. Interv. 5(5), 533-539 (2012).
85. Guetta V, Goldenberg G, Segev A et al. Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve Revalving System. Am. J. Cardiol. 108(11), 1600-1605 (2011).
86. Fraccaro C, Buja G, Tarantini G et al. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am. J. Cardiol. 107(5), 747-754 (2011).
87. Bleiziffer S, Ruge H, Horer J et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc. Interv. 3(5), 524-530 (2010).
88. Jilaihawi H, Chin D, Vasa-Nicotera M et al. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am. Heart J. 157(5), 860-866 (2009).
89. Baan J Jr, Yong ZY, Koch KT et al. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am. Heart J. 159(3), 497-503 (2010).
90. Tchetche D, Modine T, Farah B et al. Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve(R) Accutrak system. EuroIntervention 8(5), 556-562 (2012).
91. Buellesfeld L, Stortecky S, Heg D et al. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J. Am. Coll. Cardiol. 60(6), 493-501 (2012).
92. Tzikas A, Van Dalen BM, Van Mieghem NM et al. Frequency of conduction abnormalities after transcatheter aortic valve implantation with the Medtronic-CoreValve and the effect on left ventricular ejection fraction. Am. J. Cardiol. 107(2), 285-289 (2011).
93. Hoffmann R, Herpertz R, Lotfipour S et al. Impact of a new conduction defect after transcatheter aortic valve implantation on left ventricular function. JACC Cardiovasc. Interv. 5(12), 1257-1263 (2012).
94. Genereux P, Head SJ, Wood DA et al. Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur. Heart J. 33(19), 2388-2398 (2012).
95. Rezq A, Basavarajaiah S, Latib A et al. Incidence, management, and outcomes of cardiac tamponade during transcatheter aortic valve implantation: a single-center study. JACC Cardiovasc. Interv. 5(12), 1264-1272 (2012).
96. Jilaihawi H, Chakravarty T, Weiss RE, Fontana GP, Forrester J, Makkar RR. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-CoreValve, Edwards-SAPIEN and surgical aortic valve replacement in 8,536 patients. Catheter Cardiovasc. Interv. 80(1), 128-138 (2012).
97. Aminian A, Lalmand J, Dolatabadi D. Late contained aortic root rupture and ventricular septal defect after transcatheter aortic valve implantation. Catheter Cardiovasc. Interv. 81(1), e72-e75 (2013).